BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li H, Fan C, Lu H, Feng C, He P, Yang X, Xiang C, Zuo J, Tang W. Protective role of berberine on ulcerative colitis through modulating enteric glial cells-intestinal epithelial cells-immune cells interactions. Acta Pharm Sin B 2020;10:447-61. [PMID: 32140391 DOI: 10.1016/j.apsb.2019.08.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Li C, Wang J, Ma R, Li L, Wu W, Cai D, Lu Q. Natural-derived alkaloids exhibit great potential in the treatment of ulcerative colitis. Pharmacol Res 2021;175:105972. [PMID: 34758401 DOI: 10.1016/j.phrs.2021.105972] [Reference Citation Analysis]
2 Xu X, Zhang L, Zhao Y, Xu B, Qin W, Yan Y, Yin B, Xi C, Ma L. Anti‑inflammatory mechanism of berberine on lipopolysaccharide‑induced IEC‑18 models based on comparative transcriptomics. Mol Med Rep 2020;22:5163-80. [PMID: 33174609 DOI: 10.3892/mmr.2020.11602] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Lv Q, Xing Y, Liu J, Dong D, Liu Y, Qiao H, Zhang Y, Hu L. Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation. Acta Pharm Sin B 2021;11:2880-99. [PMID: 34589402 DOI: 10.1016/j.apsb.2021.03.011] [Reference Citation Analysis]
4 Cheng Y, Ji Y, Tong J. Triple stimuli-responsive supramolecular nanoassembly with mitochondrial targetability for chemophotothermal therapy. Journal of Controlled Release 2020;327:35-49. [DOI: 10.1016/j.jconrel.2020.08.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Shen Y, Zou Y, Chen X, Li P, Rao Y, Yang X, Sun Y, Hu H. Antibacterial self-assembled nanodrugs composed of berberine derivatives and rhamnolipids against Helicobacter pylori. J Control Release 2020;328:575-86. [PMID: 32946873 DOI: 10.1016/j.jconrel.2020.09.025] [Reference Citation Analysis]
6 Chen Y, Zheng Y, Wen S, Liu F. Regulation of MFN2 by berberine alleviates obesity exacerbated colitis. Biochem Biophys Res Commun 2020;531:250-5. [PMID: 32800336 DOI: 10.1016/j.bbrc.2020.07.051] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Ni L, Li Z, Ren H, Kong L, Chen X, Xiong M, Zhang X, Ning B, Li J. Berberine inhibits non-small cell lung cancer cell growth through repressing DNA repair and replication rather than through apoptosis. Clin Exp Pharmacol Physiol 2021. [PMID: 34448246 DOI: 10.1111/1440-1681.13582] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Liu Y, Liu X, Zhang N, Yin M, Dong J, Zeng Q, Mao G, Song D, Liu L, Deng H. Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5. Acta Pharm Sin B 2020;10:2299-312. [PMID: 33354502 DOI: 10.1016/j.apsb.2020.06.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
9 Xiang C, Liu M, Lu Q, Fan C, Lu H, Feng C, Yang X, Li H, Tang W. Blockade of TLRs-triggered macrophage activation by caffeic acid exerted protective effects on experimental ulcerative colitis. Cell Immunol 2021;365:104364. [PMID: 33932876 DOI: 10.1016/j.cellimm.2021.104364] [Reference Citation Analysis]
10 Zeng J, Yu H, Gan HT. Glial cell line-derived neurotrophic factor ameliorates dextran sulfate sodium-induced colitis in mice via a macrophage-mediated pathway. Int Immunopharmacol 2021;100:108143. [PMID: 34543979 DOI: 10.1016/j.intimp.2021.108143] [Reference Citation Analysis]
11 Jiang Y, Zhao L, Chen Q, Zhou L. Exploring the Mechanism of Berberine Intervention in Ulcerative Colitis from the Perspective of Inflammation and Immunity Based on Systemic Pharmacology. Evid Based Complement Alternat Med 2021;2021:9970240. [PMID: 34211579 DOI: 10.1155/2021/9970240] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Xie Q, Li H, Ma R, Ren M, Li Y, Li J, Chen H, Chen Z, Gong D, Wang J. Effect of Coptis chinensis franch and Magnolia officinalis on intestinal flora and intestinal barrier in a TNBS-induced ulcerative colitis rats model. Phytomedicine 2022;97:153927. [PMID: 35030387 DOI: 10.1016/j.phymed.2022.153927] [Reference Citation Analysis]
13 Ding Y, Liu B, Zhang Y, Fang F, Li X, Wang S, Wen J. Hydrogen sulphide protects mice against the mutual aggravation of cerebral ischaemia/reperfusion injury and colitis. Eur J Pharmacol 2022;914:174682. [PMID: 34871558 DOI: 10.1016/j.ejphar.2021.174682] [Reference Citation Analysis]
14 Rong Y, Hong G, Zhu N, Liu Y, Jiang Y, Liu T. Photodynamic Therapy of Novel Photosensitizer Ameliorates TNBS-Induced Ulcerative Colitis via Inhibition of AOC1. Front Pharmacol 2021;12:746725. [PMID: 34744725 DOI: 10.3389/fphar.2021.746725] [Reference Citation Analysis]
15 Jing W, Dong S, Luo X, Liu J, Wei B, Du W, Yang L, Luo H, Wang Y, Wang S, Lu H. Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites. Pharmacol Res 2021;164:105358. [PMID: 33285228 DOI: 10.1016/j.phrs.2020.105358] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
16 Zhao Y, Yang Y, Zhang J, Wang R, Cheng B, Kalambhe D, Wang Y, Gu Z, Chen D, Wang B, Huang Y. Lactoferrin-mediated macrophage targeting delivery and patchouli alcohol-based therapeutic strategy for inflammatory bowel diseases. Acta Pharm Sin B 2020;10:1966-76. [PMID: 33163347 DOI: 10.1016/j.apsb.2020.07.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
17 Lu J, Wang Z, Maimaiti M, Hui W, Abudourexiti A, Gao F. Identification of diagnostic signatures in ulcerative colitis patients via bioinformatic analysis integrated with machine learning. Hum Cell 2021. [PMID: 34731452 DOI: 10.1007/s13577-021-00641-w] [Reference Citation Analysis]
18 Cui Y, Xie J, Cai L, Zhang D, Sun J, Zhou X. Berberine regulates bone metabolism in apical periodontitis by remodelling the extracellular matrix. Oral Dis 2021. [PMID: 34874590 DOI: 10.1111/odi.14094] [Reference Citation Analysis]
19 Yang Y, Vong CT, Zeng S, Gao C, Chen Z, Fu C, Wang S, Zou L, Wang A, Wang Y. Tracking evidences of Coptis chinensis for the treatment of inflammatory bowel disease from pharmacological, pharmacokinetic to clinical studies. J Ethnopharmacol 2021;268:113573. [PMID: 33181286 DOI: 10.1016/j.jep.2020.113573] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
20 Sun Z, Li J, Dai Y, Wang W, Shi R, Wang Z, Ding P, Lu Q, Jiang H, Pei W, Zhao X, Guo Y, Liu J, Tan X, Mao T. Indigo Naturalis Alleviates Dextran Sulfate Sodium-Induced Colitis in Rats via Altering Gut Microbiota. Front Microbiol 2020;11:731. [PMID: 32425906 DOI: 10.3389/fmicb.2020.00731] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
21 Wang YM, Jia YT, Li ZX. Role of enteric glial cells in intestinal function and intestinal diseases. Shijie Huaren Xiaohua Zazhi 2020; 28(19): 979-985 [DOI: 10.11569/wcjd.v28.i19.979] [Reference Citation Analysis]
22 Zhong G, Zhang J, Guo Y, Wang Y, Wu M, Ren J, Li Y, Zhang X, Zhou B, Zhao W, Lou Y, Wang H, Ye J. IF1 inactivation attenuates experimental colitis through downregulation of neutrophil infiltration in colon mucosa. Int Immunopharmacol 2021;99:107980. [PMID: 34298397 DOI: 10.1016/j.intimp.2021.107980] [Reference Citation Analysis]
23 Jia L, Xue K, Liu J, Habotta OA, Hu L, Abdel Moneim AE. Anticolitic Effect of Berberine in Rat Experimental Model: Impact of PGE2/p38 MAPK Pathways. Mediators Inflamm 2020;2020:9419085. [PMID: 33061833 DOI: 10.1155/2020/9419085] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
24 Li G, Zhang B, Hao J, Chu X, Wiestler M, Cornberg M, Xu CJ, Liu X, Li Y. Identification of Novel Population-Specific Cell Subsets in Chinese Ulcerative Colitis Patients Using Single-Cell RNA Sequencing. Cell Mol Gastroenterol Hepatol 2021;12:99-117. [PMID: 33545427 DOI: 10.1016/j.jcmgh.2021.01.020] [Reference Citation Analysis]
25 Li B, Li H, Zhu Z, Xiang C, Xu Z, Fan C, Zhao Y, Feng C, Sun H, Zhang Y, Cai T, Tang W, Zhu W. Discovery of chiral N-2'-aryletheryl-1'-alkoxy-ethyl substituted arylisoquinolones with anti-inflammatory activity from the nucleophilic addition reactions of the thiophenols and oxazolinium. Eur J Med Chem 2021;222:113583. [PMID: 34119832 DOI: 10.1016/j.ejmech.2021.113583] [Reference Citation Analysis]
26 Yang L, Luo H, Tan D, Zhang S, Zhong Z, Wang S, Vong CT, Wang Y. A recent update on the use of Chinese medicine in the treatment of inflammatory bowel disease. Phytomedicine 2021;92:153709. [PMID: 34560518 DOI: 10.1016/j.phymed.2021.153709] [Reference Citation Analysis]
27 López-Gómez L, Szymaszkiewicz A, Zielińska M, Abalo R. Nutraceuticals and Enteric Glial Cells. Molecules 2021;26:3762. [PMID: 34205534 DOI: 10.3390/molecules26123762] [Reference Citation Analysis]